Guerra Pan Advisors’s AstraZeneca AZN Stock Holding History

Guerra Pan Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$937K	Sell	4,752 -3	-0.1%	-$578	0.58%	41
2025 Q4	$874K	Hold	4,755	–	–	0.52%	44
2025 Q3	$730K	Hold	4,755	–	–	0.44%	49
2025 Q2	$664K	Sell	4,755 -1,068	-18%	-$150K	0.44%	50
2025 Q1	$856K	Hold	5,823	–	–	0.67%	41
2024 Q4	$763K	Hold	5,823	–	–	0.55%	45
2024 Q3	$907K	Buy	5,823 +58	+1%	+$9.36K	0.73%	37
2024 Q2	$899K	Buy	5,765 +179	+3%	+$26.9K	0.75%	39
2024 Q1	$757K	Sell	5,586 -15	-0.3%	-$1.99K	0.7%	41
2023 Q4	$754K	Hold	5,601	–	–	0.72%	43
2023 Q3	$759K	Hold	5,601	–	–	0.88%	34
2023 Q2	$802K	Hold	5,601	–	–	0.89%	36
2023 Q1	$777K	Hold	5,601	–	–	0.98%	32
2022 Q4	$759K	Hold	5,601	–	–	1.04%	32
2022 Q3	$621K	Hold	5,601	–	–	0.91%	41
2022 Q2	$742K	Hold	5,601	–	–	0.92%	38
2022 Q1	$741K	Hold	5,601	–	–	0.89%	37
2021 Q4	$652K	Buy	+5,601	New	+$659K	0.65%	49

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Guerra Pan Advisors's AZN Position: Q1 2026 in Review

Guerra Pan Advisors reduced its AstraZeneca (AZN) stake by 0.06% in Q1 2026, selling an estimated $578 and leaving 4,752 shares worth $937K. The position accounts for 0.58% of the portfolio, ranked #41.

Guerra Pan Advisors first reported a position in AZN in Q4 2021 and has held it in 18 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Guerra Pan Advisors held 4,752 shares of AstraZeneca worth $937K as of Q1 2026.
Guerra Pan Advisors sold 3 AstraZeneca shares in Q1 2026, an estimated $578.
AstraZeneca made up 0.58% of Guerra Pan Advisors's portfolio in Q1 2026, its #41 holding.
Guerra Pan Advisors first reported a position in AstraZeneca in Q4 2021 and has held it in 18 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Guerra Pan Advisors's 13F filing for Q1 2026, filed 12 May 2026.